Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 20.56%-507.98K | 54.25%-732.26K | 27.55%-718.25K | -54.62%-4.19M | -43.54%-956.02K | 31.62%-639.42K | -192.45%-1.6M | -77.13%-991.41K | 5.32%-2.71M | -56.17%-666.02K |
| Net income from continuing operations | -6.36%-547.62K | -0.35%-515.78K | 37.94%-537.43K | 54.31%-2.66M | 69.50%-765.86K | 81.37%-514.86K | -211.21%-514K | -125.41%-865.97K | -279.15%-5.82M | 5.87%-2.51M |
| Remuneration paid in stock | --0 | --0 | --0 | -91.86%343.38K | --0 | --0 | --0 | --343.38K | --4.22M | --2.03M |
| Other non cashItems | 78.17%-15.16K | 67.41%-28.27K | 83.23%-17.89K | 49.90%-301.28K | 65.87%-38.37K | 34.02%-69.44K | 69.73%-86.76K | -9.94%-106.72K | -314.26%-601.34K | -37.80%-112.42K |
| Change In working capital | 199.40%54.8K | 81.18%-188.22K | 55.00%-162.93K | -211.71%-1.57M | -108.46%-151.79K | 78.51%-55.13K | -946.55%-999.82K | -361.49%-362.09K | -124.52%-503.3K | -103.47%-72.81K |
| -Change in receivables | -33.95%-125.16K | 67.32%-42.58K | -108.37%-12.67K | 174.64%216.02K | 462.57%288.33K | -2.25%-93.44K | -2,630.22%-130.28K | 222.44%151.4K | -937.21%-289.41K | -879.73%-79.53K |
| -Change in prepaid assets | 187.84%12.46K | 53.75%-28.66K | -972.07%-115.54K | 46.17%-50.89K | 118.22%12.01K | 29.22%-14.19K | -18.58%-61.96K | -69.66%13.25K | -130.81%-94.53K | -98.08%-65.9K |
| -Change in payables and accrued expense | 219.07%167.5K | 85.52%-116.98K | 93.41%-34.72K | -1,352.71%-1.73M | -722.62%-452.13K | 136.19%52.5K | -1,567.36%-807.58K | -34,754.21%-526.74K | -105.63%-119.36K | -96.60%72.62K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 20.56%-507.98K | 54.25%-732.26K | 27.55%-718.25K | -54.62%-4.19M | -43.54%-956.02K | 31.62%-639.42K | -192.45%-1.6M | -77.13%-991.41K | 5.32%-2.71M | -56.17%-666.02K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 31.06%-1.22M | -19.33%-1.58M | 20.28%-845.2K | -279.16%-5.56M | -190.75%-1.41M | -331.38%-1.77M | -207.57%-1.32M | -647.51%-1.06M | -121.35%-1.47M | -501.26%-484.38K |
| Net PPE purchase and sale | ---- | ---- | ---- | -183.47%-5.86M | ---- | ---- | ---- | ---- | -539.52%-2.07M | ---- |
| Interest received (cash flow from investment activities) | -78.17%15.16K | -67.41%28.27K | -83.23%17.89K | -49.90%301.28K | -65.87%38.37K | -34.02%69.44K | -69.73%86.76K | 9.94%106.72K | 314.26%601.34K | 37.80%112.42K |
| Net other investing changes | 32.84%-1.23M | -13.99%-1.61M | 26.04%-863.1K | ---- | ---- | -256.72%-1.84M | -96.74%-1.41M | -388.44%-1.17M | ---1 | --1.47M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 31.06%-1.22M | -19.33%-1.58M | 20.28%-845.2K | -279.16%-5.56M | -190.75%-1.41M | -331.38%-1.77M | -207.57%-1.32M | -647.51%-1.06M | -121.35%-1.47M | -501.26%-484.38K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -80.91K | 5.01M | 629K | 501.5K | 127.5K | 0 | 0 | 0 | 0 |
| Net common stock issuance | --0 | --0 | --5.01M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --629K | --501.5K | ---- | ---- | ---- | --0 | --0 |
| Net other financing activities | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | ---80.91K | --5.01M | --629K | --501.5K | --127.5K | --0 | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -40.24%4.48M | -34.06%6.79M | -73.16%3.33M | -26.70%12.41M | -61.31%5.23M | -49.33%7.5M | -35.78%10.3M | -26.70%12.41M | 34.70%16.92M | -21.59%13.51M |
| Current changes in cash | 24.26%-1.73M | 18.17%-2.39M | 267.75%3.44M | -118.43%-9.12M | -61.93%-1.86M | -69.51%-2.28M | -199.11%-2.92M | -192.45%-2.05M | -204.14%-4.17M | -276.26%-1.15M |
| Effect of exchange rate changes | 647.02%64.36K | -33.58%81.96K | 138.40%20.83K | 112.57%43.13K | -175.01%-34.64K | -84.94%8.62K | 147.21%123.39K | 70.71%-54.24K | -197.79%-343.16K | 4,617,500.00%46.17K |
| End cash Position | -46.09%2.82M | -40.24%4.48M | -34.06%6.79M | -73.16%3.33M | -73.16%3.33M | -61.31%5.23M | -49.33%7.5M | -35.78%10.3M | -26.70%12.41M | -26.70%12.41M |
| Free cash from | 20.56%-507.98K | 54.25%-732.26K | 27.55%-718.25K | -110.41%-10.05M | -149.38%-6.82M | 31.62%-639.42K | -192.45%-1.6M | -77.13%-991.41K | -50.02%-4.78M | -264.61%-2.73M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.